"Real-life" Cohort Study on Patients With Chronic HBV Infection in Jiangsu
"Real-life" Cohort Study on Patients With Chronic HBV Infection in Jiangsu
Hepatitis B virus (HBV) infection remains one of the most serious health problems worldwide.
 Patients with chronic HBV infection are at an increased risk for developing hepatic
 cirrhosis, hepatocellular carcinoma and even death. Although some predictive factors of the
 outcome of chronic HBV infection were identified, more precisely determine the factors which
 are associated with the outcome in non-selected patients with chronic HBV infection are still
 needed. The investigators purpose is to constitute a observational cohort of non-selected
 Chinese patients to create a database of epidemiological, clinical, biological, virological,
 immunologic and therapeutic parameters, in order to determine factors associated with the
 outcome of chronic HBV infection.
Inclusion Criteria:

 -  Patients with chronic HBV infection (defined as HBsAg positive for at least 6 months)

 Exclusion Criteria:

 -  Co-infection with human immunodeficiency virus (HIV), hepatitis C virus (HCV) and/or
 hepatitis D virus (HDV)

 -  History of liver transplantation

 -  History of hepatocellular carcinoma (HCC)